Home
Resources
Diseases
COVID-19
Ebola
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hepatitis B birth dose vaccines
Hexavalent vaccines
HPV vaccines
Malaria vaccines
Measles containing vaccines
PCV vaccines
RSV vaccines
Typhoid Conjugate Vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (2)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1199)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (161)
Global (1)
South-East Asia (12)
Western Pacific (39)
Diseases
COVID-19 (1599)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (45)
Diphtheria (92)
Ebola (21)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (72)
Hepatitis A (71)
Hepatitis B (175)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (81)
HIV / AIDS (10)
Human papillomavirus (HPV) (545)
Influenza (639)
Japanese encephalitis (35)
Lyme disease, Borreliosis (2)
Malaria (35)
Measles (148)
Meningococcal disease (157)
Moraxella catarrhalis (1)
Mpox (59)
Mumps (53)
Pertussis (122)
Pneumococcal disease (310)
Poliomyelitis (98)
Q fever (1)
Rabies (33)
Rotavirus (122)
RSV (Respiratory syncytial virus) (71)
Rubella (72)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (73)
Tick-borne encephalitis (14)
Tuberculosis (84)
Typhoid (33)
Varicella (79)
Yellow fever (45)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (14)
Moderate (9)
Low (132)
Critically low (732)
Not applicable (312)
1599 results found
2020
∙
ACIP, Nancy McClung
Epidemiology of Individuals at Increased Risk of COVID-19 Disease
2020
∙
Mary Chamberland, ACIP
Ethical Principles for Phased Allocation of COVID-19 Vaccines
2020
∙
Sara Oliver, ACIP
EtR Framework: Moderna COVID-19 vaccine
2020
∙
ACIP, Sara Oliver
EtR Framework: Public Health Problem, Resource Use and Equity Domains
2020
∙
Sara Oliver, ACIP
EtR Framework: Values, Acceptability and Feasibility Domains
2020
∙
Sara Oliver, ACIP
Evidence to Recommendations Framework: Pfizer-BioNTech COVID-19 vaccine
2020
∙
Health Council of the Netherlands
Executive summary of the COVID-19 and vaccination against pneumococci (2)
2020
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Moderna COVID-19 Vaccine
2020
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer BioNTech COVID-19 Vaccine
2020
∙
NACI, Public Health Agency of Canada
Guidance on the prioritization of initial doses of COVID-19 vaccine(s)
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
